Propofol versus thiopental sodium for the treatment of refractory status epilepticus (Review)

Evidence-Based Child Health

Volumn 8, Issue 4, 2013, Pages 1488-1508

  Prabhakar, Hemanshu ^a   Bindra, Ashish ^a   Singh, Gyaninder Pal ^a   Kalaivani, Mani ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Adult; Anesthetics; Anticonvulsants therapeutic use ; Humans; Intravenous therapeutic use ; Propofol therapeutic use ; Status Epilepticus drug therapy ; Thiopental therapeutic use

Indexed keywords

PROPOFOL; THIOPENTAL;

ARTICLE; ARTIFICIAL VENTILATION; DISEASE CONTROL; DRUG EFFICACY; DRUG SAFETY; EPILEPTIC STATE; HUMAN; HYPOTENSION; INFECTION; LENGTH OF STAY; MORTALITY; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPOFOL INFUSION SYNDROME; RANDOMIZED CONTROLLED TRIAL (TOPIC); REFRACTORY STATUS EPILEPTICUS; RISK ASSESSMENT; SENSITIVITY ANALYSIS;

ADULT; ANESTHETICS; ANTICONVULSANTS [THERAPEUTIC USE]; HUMANS; INTRAVENOUS [THERAPEUTIC USE]; PROPOFOL [THERAPEUTIC USE]; STATUS EPILEPTICUS [DRUG THERAPY]; THIOPENTAL [THERAPEUTIC USE];

ANESTHETICS, INTRAVENOUS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; PROPOFOL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STATUS EPILEPTICUS; THIOPENTAL; TIME FACTORS; TREATMENT OUTCOME;

EID: 84880341769     PISSN: None     EISSN: 15576272     Source Type: Journal    
DOI: 10.1002/ebch.1929     Document Type: Article

References (38)

1. References to studies included in this review
2. Rossetti 2011 {published data only}
3. Rossetti AO, Milligan TA, Vulliemoz S, Michaelides C, Bertschi M, Lee JW. A randomized trial for the treatment of refractory status epilepticus. Neurocritical Care 2011;14:4-10. [DOI: 20878265]
4. Additional references
5. Claassen 2002
6. Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia 2002;43(2):146-53. [PUBMED: 11903460 ]
7. Higgins 2002
8. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21(11):1539-58. [PUBMED: 12111919]
9. Higgins 2008
10. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
11. Holtkamp 2007
12. Holtkamp M. The anaesthetic and intensive care of status epilepticus. Current Opinion in Neurology 2007;20(2):188-93. [PUBMED: 17351490 ]
13. Lefebvre 2009
14. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
15. Marik 2004
16. Marik PE. Propofol: therapeutic indications and side effects. Current Pharmaceutical Design 2004;10(29):3639-49. [PUBMED: 15579060 ]
17. Mayer 2002
18. Mayer SA, Claasen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons BF. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Archives of Neurology 2002;59(2):205-10. [PUBMED: 11843690 ]
19. Parviainen 2002
20. Parviainen I, Uusaro A, Kalviainen R, Kaukanen E, Mervaala E, Ruokonen E. High-dose thiopental in the treatment of refractory status epilepticus in intensive care unit. Neurology 2002;59(8):1249-51. [PUBMED: 12391357 ]
21. Prasad 2005
22. Prasad K, Al-Roomi K, Krishnan PR, Sequeira R. Anticonvulsant therapy for status epilepticus. Cochrane Database of Systematic Reviews 2005, Issue 4. [DOI: 10.1002/14651858.CD003723.pub2]
23. RevMan 2011
24. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan) 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
25. Rogowski 2004
26. Rogowski MA, Loscher W. The neurobiology of antiepileptic drugs. Nature Reviews Neuroscience 2004;5(7):553-64. [PUBMED: 15208697 ]
27. Rossetti 2005
28. Rossetti AO, Logroscino G, Bromfield EB. Refractory status epilepticus. Effects of treatment aggressiveness on prognosis. Archives of Neurology 2005;62(11):1698-702. [PUBMED: 16286542 ]
29. Treiman 1998
30. Treiman DM, Meyers PD, Walton NY, Colling C, Rowan AJ, Handforth A, et al.A comparison of four treatments for generalized convulsive status epilepticus: Veterans Affairs Status Epilepticus Cooperative Study Group. New England Journal of Medicine 1998;339(12):792-8. [PUBMED: 9738086]
31. Van Gestel 2005
32. Van Gestel JP, Blussé Van Oud-Alblas HJ, Malingré M, Ververs FF, Braun KP, Van Nieuwenhuizen O. Propofol and thiopental for refractory status epilepticus in children. Neurology 2005;65(4):591-2. [PUBMED: 16116121 ]
33. Working Group 1993
34. Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus. JAMA 1993;270(7):854-9. [PUBMED: 8340986 ]
35. Zarovnaya 2007
36. Zarovnaya EL, Jobst BC, Harris BT. Propofol-associated fatal myocardial failure and rhabdomyolysis in an adult with status epilepticus. Epilepsia 2007;48(5):1002-6. [PUBMED: 17381434 ]
37. Zhan 2001
38. Zhan RZ, Qi S, Wu C, Fujihara H, Taga K, Shimoji K. Intravenous anaesthetics differentially reduce neurotransmission damage caused by oxygen-glucose deprivation in rat hippocampal slices in correlation with N-methyl-D-aspartate receptor inhibition. Critical Care Medicine 2001;29(4):808-13. [PUBMED: 11373474 ]